ロード中...

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance

Doxorubicin (DOX), an anthracycline, is broadly considered the most active single agent available for treating breast cancer but has been known to induce cardiotoxicity. Although DOX is highly effective in treating triple-negative breast cancer (TNBC), DOX can have poor outcomes owing to induction o...

詳細記述

保存先:
書誌詳細
出版年:Biomed Res Int
主要な著者: Robinson, Prema, Kasembeli, Moses, Bharadwaj, Uddalak, Engineer, Nikita, Eckols, Kris T., Tweardy, David J.
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4766315/
https://ncbi.nlm.nih.gov/pubmed/26981525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1959270
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!